SARS-inhibitor 3, 1mg

Overview

SARS-inhibitor 3 is a crucial tool for researchers focusing on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic. This peptide plays an essential role in the ongoing efforts to combat viral infectivity by specifically targeting the virus-host cell interaction and hindering virus replication. By inhibiting the spike protein of SARS-CoV-2 from binding to the ACE2 enzyme, a primary receptor for the virus, SARS-inhibitor 3 offers a valuable approach for studying potential therapeutic interventions against COVID-19.

Key Features

• Specifically inhibits the binding of SARS-CoV-2 spike protein to ACE2 receptor
• Supports research into SARS inhibitors and virology
• Available in a convenient 1 mg format for easy use
• Ideal for academic, clinical, and pharmaceutical research applications
• Complementary products available, such as PKG Substrate and Autocamtide-2

Specifications

FAQ

What is SARS-inhibitor 3?

SARS-inhibitor 3 is a peptide designed to inhibit the spike protein of SARS-CoV-2 from binding to the ACE2 receptor, making it a valuable resource in COVID-19 research.

How can I use SARS-inhibitor 3 in my research?

This peptide can be used in a variety of assays and experiments aimed at understanding SARS-CoV-2 interactions and testing potential therapeutic strategies.

Are there related products available?

Yes, we offer a range of related products, including other peptides that may enhance your research, such as CREBtide.

For those looking to deepen their research into peptides and proteins, check out our extensive catalog of peptides.